Corcept Therapeutics CORT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's total current assets?
- Corcept Therapeutics (CORT) reported total current assets of $426.03M in Q1 2026.
- How has Corcept Therapeutics's total current assets changed year-over-year?
- Corcept Therapeutics's total current assets decreased by 2.8% year-over-year, from $438.5M to $426.03M.
- What is the long-term trend for Corcept Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's total current assets has grown at a 0.3% compound annual growth rate (CAGR), from $478.5M to $485.46M.
- What does total current assets mean?
- The sum of all assets that the company expects to turn into cash within one year.
- How do you interpret total current assets?
- Higher levels indicate greater short-term financial flexibility and a stronger ability to cover current liabilities.
- How does total current assets compare across companies?
- Standard metric across all industries; essential for assessing short-term solvency.